WuXi AppTec

About:

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical.

Top Investors: NewSpring, Warburg Pincus, Eight Roads Ventures, Ping An Bank, Commerce Health Capital

Description:

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".

Total Funding Amount:

$1.59B

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2000-12-01

Contact Email:

tech(AT)4abio.com

Founders:

Ge Li, John J. Baldwin, Zhaohui Zhang